美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

SPYRE THERAPEUTICS INC

89.33

-1.0300-1.14%

盤後：89.330.00000.00%19:30 EDT

成交量：191.32萬

成交額：1.70億

市值：78.77億

市盈率：-44.44

高：90.97

開：89.15

低：86.40

收：90.36

52周最高：110.18

52周最低：14.51

股本：8,817.38萬

流通股本：8,097.70萬

量比：1.35

換手率：2.36%

股息：- -

股息率：- -

每股收益(TTM):-2.0100

每股收益(LYR):-1.9755

淨資產收益率：-22.98%

總資產收益率：-19.81%

市淨率：8.25

市盈率(LYR):-45.22

資料載入中...

總覽公司新聞公告

Spyre Therapeutics宣佈Skyway籃子試驗完成患者入組，評估Spy072（抗TL1A）治療RA、PsA及AxSpa

Spyre Therapeutics重申預期：類風濕關節炎試驗數據將於2026年第三季度揭曉，銀屑病關節炎與中軸型脊柱關節炎數據預計第四季度公布

Spyre Therapeutics：Skyway與Skyline試驗齊頭並進，計劃中的「2026年六項」二期數據讀出已就緒並按計劃推進

Spyre Therapeutics重大協議觸發條款：2028年6月1日後初始領域外給藥限制將解除

Spyre Therapeutics 與 Paragon Therapeutics 簽署許可協議首次修訂案

Spyre Therapeutics公布2026年一季度財務數據：現金及等價物達7.415億美元資金可支撐運營至2029年下半年

BUZZ-Spyre Therapeutics 在 4.03 億美元的股票銷售提振後上漲

異動解讀 | Spyre Therapeutics獲強力買入評級，盤前大漲6.99%

【券商聚焦】華爾街頂尖分析師調整閃迪等多家企業評級展望

Spyre Therapeutics公司宣佈暫停並終止ATM發行招股説明書 2026年4月13日正式生效

BUZZ--美國股票走勢-Allogene Therapeutics、Adobe、Williams-Sonoma

BUZZ-腸道疾病藥物中期研究成功，Spyre 股價上漲

Spyre Therapeutics高管：中期研究顯示SPY001單藥療效在部分指標上媲美或超越強生聯合療法

Spyre盤前股價上漲23%

每日经济新闻

SPYRE THERAPEUTICS INC股價盤前飆升23% 公司宣佈炎症性腸病藥物中期研究顯示疾病活動度降低

Spyre公布Skyline試驗中重度潰瘍性結腸患者Spy001 Part a誘導期潛在最佳療效數據

Spyre Therapeutics：誘導治療期間六名受試者出現治療突發不良事件

Spyre Therapeutics藥物Spy001達成主要終點：RHI評分顯著降低9.2分，統計學差異凸顯

Spyre公司的炎症性腸病藥物在中期研究中減輕了疾病活動性

Spyre Therapeutics次要終點數據亮眼：改良Mayo評分臨床緩解率達40%，內鏡改善率51%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/SYRE/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SYRE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SYRE\",,,,,undefined,":{"symbol":"SYRE","market":"US","secType":"STK","nameCN":"SPYRE THERAPEUTICS INC","latestPrice":89.33,"timestamp":1788206400000,"preClose":90.36,"halted":0,"volume":1913157,"hourTrading":{"tag":"盘后","latestPrice":89.33,"preClose":89.33,"latestTime":"19:30 EDT","volume":252023,"amount":22513171.04498,"timestamp":1788219002481,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.01139884904825145,"floatShares":80977000,"shares":88173800,"eps":-2.009956,"marketStatus":"未開盤","change":-1.03,"latestTime":"08-31 16:00:00 EDT","open":89.15,"high":90.965,"low":86.4,"amount":169534790.1864,"amplitude":0.05052,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.009956,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":0,"adr":0,"listingDate":1460001600000,"exchange":"NASDAQ","adjPreClose":90.36,"preHourTrading":{"tag":"盘前","latestPrice":88.13,"preClose":90.36,"latestTime":"09:29 EDT","volume":763,"amount":68221.45519000001,"timestamp":1788182999999,"change":-2.23,"changeRate":-0.024679,"amplitude":0.02479},"postHourTrading":{"tag":"盘后","latestPrice":89.33,"preClose":89.33,"latestTime":"19:30 EDT","volume":252023,"amount":22513171.04498,"timestamp":1788219002481,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.345119,"impliedVol":0.8996,"impliedVolPercentile":0.7729},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SYRE\",,,,,undefined,":{"symbol":"SYRE","floatShares":80977000,"roa":"-19.81%","roe":"-22.98%","lyrEps":-1.975476,"volumeRatio":1.345119,"shares":88173800,"dividePrice":0,"high":90.965,"amplitude":0.05052,"preClose":90.36,"low":86.4,"week52Low":14.505,"pbRate":"8.25","week52High":110.175,"institutionHeld":0,"latestPrice":89.33,"eps":-2.009956,"divideRate":0,"volume":1913157,"delay":0,"ttmEps":-2.009956,"open":89.15,"prevYearClose":32.76,"prevWeekClose":90.36,"prevMonthClose":98.33,"prevQuarterClose":88.78,"fiveDayClose":106.65,"twentyDayClose":94.93,"sixtyDayClose":78.48},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SYRE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"SYRE","fiscalQuarterEnding":"2026/06","expectedEps":-0.71,"name":null,"time":"盤後","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"post","actualEps":-0.36},{"market":"US","date":"2026-05-05","symbol":"SYRE","fiscalQuarterEnding":"2026/03","expectedEps":-0.66,"name":null,"time":"盤前","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"pre","actualEps":-0.74},{"market":"US","date":"2026-02-19","symbol":"SYRE","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1771477200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-04","symbol":"SYRE","fiscalQuarterEnding":"2025/09","expectedEps":-0.68,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2025-08-05","symbol":"SYRE","fiscalQuarterEnding":"2025/06","expectedEps":-0.73,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-0.49}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SYRE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SYRE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5294,"buy":0.4118,"hold":0.0588,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4118,"analysts":17,"updateTime":1785470400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SYRE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SYRE","date":"2026-08-28","current":-44.443759,"percent":0.049635,"low":-53.677585,"twenty":-18.037414,"median":-6.00579,"eighty":-4.082736,"high":-0.199399,"avg":-12.382014,"sd":13.405227,"marketCap":8254386729},"quantilePoints":[{"date":"2023-12-01","current":-1.902619,"twenty":-1.228042,"median":-0.216176,"eighty":-0.20611,"marketCap":560191990},{"date":"2023-12-08","current":-2.024974,"twenty":-2.048834,"median":-1.98164,"eighty":-0.890753,"marketCap":596217199},{"date":"2023-12-15","current":-1.815535,"twenty":-2.023412,"median":-1.966856,"eighty":-1.735642,"marketCap":534551743},{"date":"2023-12-22","current":-2.106706,"twenty":-2.023412,"median":-1.950531,"eighty":-1.82549,"marketCap":620281740},{"date":"2023-12-29","current":-2.507984,"twenty":-2.09023,"median":-1.996425,"eighty":-1.840422,"marketCap":738430643},{"date":"2024-01-05","current":-2.757559,"twenty":-2.278228,"median":-2.002935,"eighty":-1.873937,"marketCap":811913497},{"date":"2024-01-12","current":-2.567931,"twenty":-2.588728,"median":-2.024974,"eighty":-1.89995,"marketCap":756080936},{"date":"2024-01-19","current":-2.66458,"twenty":-2.653814,"median":-2.09023,"eighty":-1.902486,"marketCap":784537532},{"date":"2024-01-26","current":-3.303198,"twenty":-2.742878,"median":-2.292052,"eighty":-1.915254,"marketCap":972567189},{"date":"2024-02-02","current":-3.16373,"twenty":-3.116751,"median":-2.567931,"eighty":-1.947266,"marketCap":931503241},{"date":"2024-02-09","current":-2.89825,"twenty":-3.138772,"median":-2.61809,"eighty":-1.978684,"marketCap":853337655},{"date":"2024-02-16","current":-2.760005,"twenty":-3.112591,"median":-2.66458,"eighty":-1.997649,"marketCap":812633917},{"date":"2024-02-23","current":-2.496973,"twenty":-3.08641,"median":-2.66458,"eighty":-2.000865,"marketCap":735188752},{"date":"2024-03-01","current":-3.357028,"twenty":-3.117974,"median":-2.696389,"eighty":-2.009323,"marketCap":988416432},{"date":"2024-03-08","current":-4.14553,"twenty":-3.186241,"median":-2.748383,"eighty":-2.021849,"marketCap":1404464057},{"date":"2024-03-15","current":-4.473117,"twenty":-3.315921,"median":-2.757559,"eighty":-2.032927,"marketCap":1515447446},{"date":"2024-03-22","current":-4.253303,"twenty":-3.374155,"median":-2.84075,"eighty":-2.069838,"marketCap":1440976508},{"date":"2024-03-28","current":-3.948124,"twenty":-3.948124,"median":-2.884793,"eighty":-2.09023,"marketCap":1337584817},{"date":"2024-04-05","current":-3.822655,"twenty":-3.997689,"median":-2.933117,"eighty":-2.106706,"marketCap":1295077328},{"date":"2024-04-12","current":-4.169482,"twenty":-4.017483,"median":-2.950857,"eighty":-2.22293,"marketCap":1412578691},{"date":"2024-04-19","current":-3.844264,"twenty":-4.019298,"median":-3.071974,"eighty":-2.361175,"marketCap":1302398285},{"date":"2024-04-26","current":-3.508242,"twenty":-4.017483,"median":-3.149049,"eighty":-2.496973,"marketCap":1188557401},{"date":"2024-05-03","current":-4.312212,"twenty":-4.026871,"median":-3.180093,"eighty":-2.505537,"marketCap":1460934345},{"date":"2024-05-10","current":-4.183809,"twenty":-4.050631,"median":-3.290964,"eighty":-2.507984,"marketCap":1417432578},{"date":"2024-05-17","current":-4.180278,"twenty":-4.096445,"median":-3.334395,"eighty":-2.567931,"marketCap":1522561849},{"date":"2024-05-24","current":-3.614061,"twenty":-4.096445,"median":-3.364368,"eighty":-2.569154,"marketCap":1316331249},{"date":"2024-05-31","current":-4.872934,"twenty":-4.111605,"median":-3.38639,"eighty":-2.608303,"marketCap":1774844320},{"date":"2024-06-07","current":-4.694469,"twenty":-4.171641,"median":-3.527045,"eighty":-2.61809,"marketCap":1709842869},{"date":"2024-06-14","current":-4.393309,"twenty":-4.193693,"median":-3.59738,"eighty":-2.63375,"marketCap":1600152919},{"date":"2024-06-21","current":-3.360163,"twenty":-4.181695,"median":-3.573485,"eighty":-2.653814,"marketCap":1223855454},{"date":"2024-06-28","current":-3.277902,"twenty":-4.180281,"median":-3.545724,"eighty":-2.666048,"marketCap":1193893847},{"date":"2024-07-05","current":-3.553965,"twenty":-4.180278,"median":-3.545724,"eighty":-2.674367,"marketCap":1294442968},{"date":"2024-07-12","current":-4.13816,"twenty":-4.17596,"median":-3.564426,"eighty":-2.694186,"marketCap":1507221157},{"date":"2024-07-19","current":-4.113063,"twenty":-4.180278,"median":-3.593701,"eighty":-2.712782,"marketCap":1498080328},{"date":"2024-07-26","current":-4.387732,"twenty":-4.219183,"median":-3.614061,"eighty":-2.731867,"marketCap":1598121624},{"date":"2024-08-02","current":-3.651563,"twenty":-4.192391,"median":-3.674487,"eighty":-2.752053,"marketCap":1329990636},{"date":"2024-08-09","current":-6.773008,"twenty":-4.238871,"median":-3.689208,"eighty":-2.757559,"marketCap":1259650875},{"date":"2024-08-16","current":-7.111659,"twenty":-4.267009,"median":-3.707046,"eighty":-2.757559,"marketCap":1322633418},{"date":"2024-08-23","current":-6.972375,"twenty":-4.305721,"median":-3.744862,"eighty":-2.758537,"marketCap":1296729308},{"date":"2024-08-30","current":-7.851774,"twenty":-4.372067,"median":-3.796365,"eighty":-2.792303,"marketCap":1460280752},{"date":"2024-09-06","current":-7.655166,"twenty":-4.395693,"median":-3.839237,"eighty":-2.844176,"marketCap":1423715511},{"date":"2024-09-13","current":-8.038472,"twenty":-4.515004,"median":-3.909092,"eighty":-2.863261,"marketCap":1495003126},{"date":"2024-09-20","current":-8.260242,"twenty":-4.753435,"median":-3.923931,"eighty":-2.887484,"marketCap":1536248103},{"date":"2024-09-27","current":-7.800275,"twenty":-4.893011,"median":-3.931452,"eighty":-2.904612,"marketCap":1450702965},{"date":"2024-10-04","current":-7.980976,"twenty":-5.268067,"median":-3.990592,"eighty":-2.931282,"marketCap":1484309983},{"date":"2024-10-11","current":-7.857771,"twenty":-6.760445,"median":-4.004311,"eighty":-2.936176,"marketCap":1461396107},{"date":"2024-10-18","current":-8.969358,"twenty":-6.959266,"median":-4.01434,"eighty":-2.939112,"marketCap":1668130191},{"date":"2024-10-25","current":-9.530627,"twenty":-7.262959,"median":-4.019298,"eighty":-2.969942,"marketCap":1772515627},{"date":"2024-11-01","current":-9.303382,"twenty":-7.505129,"median":-4.04736,"eighty":-3.046528,"marketCap":1730252255},{"date":"2024-11-08","current":-9.47125,"twenty":-7.585076,"median":-4.070861,"eighty":-3.057293,"marketCap":2035390531},{"date":"2024-11-15","current":-6.988263,"twenty":-7.603794,"median":-4.087936,"eighty":-3.101825,"marketCap":1501791624},{"date":"2024-11-22","current":-7.566995,"twenty":-7.593388,"median":-4.106049,"eighty":-3.128495,"marketCap":1626162294},{"date":"2024-11-29","current":-7.766414,"twenty":-7.602508,"median":-4.133831,"eighty":-3.149049,"marketCap":1669017834},{"date":"2024-12-06","current":-7.397625,"twenty":-7.602508,"median":-4.146835,"eighty":-3.16373,"marketCap":1589764437},{"date":"2024-12-13","current":-6.589022,"twenty":-7.597044,"median":-4.169482,"eighty":-3.166361,"marketCap":1415994026},{"date":"2024-12-20","current":-6.517996,"twenty":-7.595055,"median":-4.180278,"eighty":-3.169847,"marketCap":1400730409},{"date":"2024-12-27","current":-6.466093,"twenty":-7.588386,"median":-4.182047,"eighty":-3.186241,"marketCap":1389576227},{"date":"2025-01-03","current":-6.651853,"twenty":-7.58308,"median":-4.215671,"eighty":-3.191991,"marketCap":1429496457},{"date":"2025-01-10","current":-6.135549,"twenty":-7.579794,"median":-4.247699,"eighty":-3.203592,"marketCap":1318541701},{"date":"2025-01-17","current":-5.632904,"twenty":-7.573901,"median":-4.253955,"eighty":-3.236074,"marketCap":1210522256},{"date":"2025-01-24","current":-5.900617,"twenty":-7.564263,"median":-4.27898,"eighty":-3.264517,"marketCap":1268054352},{"date":"2025-01-31","current":-6.280332,"twenty":-7.548513,"median":-4.304099,"eighty":-3.280514,"marketCap":1349655997},{"date":"2025-02-07","current":-6.187452,"twenty":-7.528128,"median":-4.345056,"eighty":-3.293411,"marketCap":1329695883},{"date":"2025-02-14","current":-6.26121,"twenty":-7.522652,"median":-4.382852,"eighty":-3.305947,"marketCap":1345546562},{"date":"2025-02-21","current":-5.815932,"twenty":-7.518271,"median":-4.394799,"eighty":-3.316941,"marketCap":1249855423},{"date":"2025-02-28","current":-5.708297,"twenty":-7.512359,"median":-4.473117,"eighty":-3.319102,"marketCap":1187428551},{"date":"2025-03-07","current":-5.647447,"twenty":-7.483663,"median":-4.605135,"eighty":-3.349687,"marketCap":1174770683},{"date":"2025-03-14","current":-5.227293,"twenty":-7.452562,"median":-4.749486,"eighty":-3.357028,"marketCap":1087371120},{"date":"2025-03-21","current":-5.264962,"twenty":-7.449529,"median":-4.833391,"eighty":-3.360163,"marketCap":1095206943},{"date":"2025-03-28","current":-5.198317,"twenty":-7.397625,"median":-4.89803,"eighty":-3.364368,"marketCap":1081343564},{"date":"2025-04-04","current":-3.706047,"twenty":-7.375771,"median":-4.833391,"eighty":-3.376602,"marketCap":770924425},{"date":"2025-04-11","current":-3.540883,"twenty":-7.371109,"median":-4.749486,"eighty":-3.378289,"marketCap":736567355},{"date":"2025-04-17","current":-3.671275,"twenty":-7.352984,"median":-4.694469,"eighty":-3.38477,"marketCap":763691357},{"date":"2025-04-25","current":-4.094327,"twenty":-7.328784,"median":-4.51381,"eighty":-3.412624,"marketCap":851693676},{"date":"2025-05-02","current":-4.378293,"twenty":-7.296115,"median":-4.473117,"eighty":-3.422161,"marketCap":910763726},{"date":"2025-05-09","current":-4.072986,"twenty":-7.269514,"median":-4.422481,"eighty":-3.450063,"marketCap":850985210},{"date":"2025-05-16","current":-4.384959,"twenty":-7.258044,"median":-4.393309,"eighty":-3.492778,"marketCap":916167055},{"date":"2025-05-23","current":-4.353184,"twenty":-7.252035,"median":-4.386346,"eighty":-3.506946,"marketCap":909528164},{"date":"2025-05-30","current":-4.491839,"twenty":-7.242247,"median":-4.381626,"eighty":-3.527827,"marketCap":938497873},{"date":"2025-06-06","current":-4.800924,"twenty":-7.228256,"median":-4.393309,"eighty":-3.543713,"marketCap":1003076183},{"date":"2025-06-13","current":-5.115786,"twenty":-7.156112,"median":-4.413455,"eighty":-3.545748,"marketCap":1068861565},{"date":"2025-06-20","current":-4.356073,"twenty":-7.062301,"median":-4.413455,"eighty":-3.549094,"marketCap":910131699},{"date":"2025-06-27","current":-4.627605,"twenty":-6.984824,"median":-4.413846,"eighty":-3.558149,"marketCap":966864047},{"date":"2025-07-03","current":-4.5525,"twenty":-6.978207,"median":-4.413846,"eighty":-3.566238,"marketCap":951172121},{"date":"2025-07-11","current":-4.610273,"twenty":-6.959266,"median":-4.434912,"eighty":-3.576816,"marketCap":963242833},{"date":"2025-07-18","current":-4.878917,"twenty":-6.905553,"median":-4.448509,"eighty":-3.590436,"marketCap":1019371645},{"date":"2025-07-25","current":-5.084011,"twenty":-6.899536,"median":-4.462257,"eighty":-3.592447,"marketCap":1062222673},{"date":"2025-08-01","current":-4.902026,"twenty":-6.889009,"median":-4.488402,"eighty":-3.59611,"marketCap":1024199930},{"date":"2025-08-08","current":-4.450911,"twenty":-6.843738,"median":-4.500505,"eighty":-3.597671,"marketCap":920510630},{"date":"2025-08-15","current":-4.924039,"twenty":-6.770823,"median":-4.509171,"eighty":-3.60188,"marketCap":1018360185},{"date":"2025-08-22","current":-4.900675,"twenty":-6.760445,"median":-4.52404,"eighty":-3.616232,"marketCap":1013528108},{"date":"2025-08-29","current":-4.883151,"twenty":-6.744059,"median":-4.5525,"eighty":-3.624946,"marketCap":1009904051},{"date":"2025-09-05","current":-4.962006,"twenty":-6.704732,"median":-4.610273,"eighty":-3.625072,"marketCap":1026212310},{"date":"2025-09-12","current":-4.731283,"twenty":-6.670975,"median":-4.650968,"eighty":-3.630649,"marketCap":978495552},{"date":"2025-09-19","current":-4.474275,"twenty":-6.670975,"median":-4.610273,"eighty":-3.651563,"marketCap":925342707},{"date":"2025-09-26","current":-4.558971,"twenty":-6.651853,"median":-4.590463,"eighty":-3.659766,"marketCap":942858985},{"date":"2025-10-03","current":-4.667031,"twenty":-6.651853,"median":-4.640746,"eighty":-3.671275,"marketCap":965207340},{"date":"2025-10-10","current":-6.182794,"twenty":-6.639187,"median":-4.66411,"eighty":-3.682866,"marketCap":1278688323},{"date":"2025-10-17","current":-6.495292,"twenty":-6.589022,"median":-4.675298,"eighty":-3.682866,"marketCap":1343317350},{"date":"2025-10-24","current":-8.382293,"twenty":-6.651853,"median":-4.679157,"eighty":-3.689208,"marketCap":1733575542},{"date":"2025-10-31","current":-9.090497,"twenty":-6.704732,"median":-4.696933,"eighty":-3.700564,"marketCap":1880042140},{"date":"2025-11-07","current":-11.662076,"twenty":-6.790267,"median":-4.714264,"eighty":-3.706047,"marketCap":1737287790},{"date":"2025-11-14","current":-11.787083,"twenty":-6.900444,"median":-4.731283,"eighty":-3.707046,"marketCap":1755909901},{"date":"2025-11-21","current":-12.224606,"twenty":-6.988263,"median":-4.745208,"eighty":-3.707046,"marketCap":1821087291},{"date":"2025-11-28","current":-15.625828,"twenty":-7.239349,"median":-4.751954,"eighty":-3.713244,"marketCap":2327763900},{"date":"2025-12-05","current":-17.454049,"twenty":-7.296115,"median":-4.772037,"eighty":-3.728167,"marketCap":2600112276},{"date":"2025-12-12","current":-17.896781,"twenty":-7.380142,"median":-4.779357,"eighty":-3.742192,"marketCap":2666065586},{"date":"2025-12-19","current":-17.433215,"twenty":-7.489402,"median":-4.800924,"eighty":-3.751648,"marketCap":2597008591},{"date":"2025-12-26","current":-17.214453,"twenty":-7.525937,"median":-4.815979,"eighty":-3.763383,"marketCap":2564419896},{"date":"2026-01-02","current":-17.063404,"twenty":-7.573901,"median":-4.841253,"eighty":-3.771122,"marketCap":2541918178},{"date":"2026-01-09","current":-15.698748,"twenty":-7.596248,"median":-4.85056,"eighty":-3.792677,"marketCap":2338626798},{"date":"2026-01-16","current":-17.235288,"twenty":-7.641035,"median":-4.868549,"eighty":-3.827277,"marketCap":2567523581},{"date":"2026-01-23","current":-17.756149,"twenty":-7.65516,"median":-4.878917,"eighty":-3.836222,"marketCap":2645115711},{"date":"2026-01-30","current":-17.49051,"twenty":-7.716495,"median":-4.891913,"eighty":-3.850233,"marketCap":2605543725},{"date":"2026-02-06","current":-17.157159,"twenty":-7.797537,"median":-4.900675,"eighty":-3.876725,"marketCap":2555884762},{"date":"2026-02-13","current":-18.146794,"twenty":-7.885881,"median":-4.903471,"eighty":-3.891573,"marketCap":2703309809},{"date":"2026-02-20","current":-23.527864,"twenty":-7.934432,"median":-4.916265,"eighty":-3.909092,"marketCap":3504922382},{"date":"2026-02-27","current":-21.83597,"twenty":-8.038472,"median":-4.931737,"eighty":-3.918816,"marketCap":3389008076},{"date":"2026-03-06","current":-20.540487,"twenty":-8.323214,"median":-4.953617,"eighty":-3.922049,"marketCap":3187945256},{"date":"2026-03-13","current":-20.449399,"twenty":-8.618907,"median":-4.962688,"eighty":-3.925813,"marketCap":3173808027},{"date":"2026-03-20","current":-21.41089,"twenty":-8.906386,"median":-4.973688,"eighty":-3.927002,"marketCap":3323034338},{"date":"2026-03-27","current":-24.0474,"twenty":-8.969358,"median":-4.994463,"eighty":-3.931452,"marketCap":3732228593},{"date":"2026-04-02","current":-24.745746,"twenty":-9.172768,"median":-5.075907,"eighty":-3.931939,"marketCap":3840614019},{"date":"2026-04-10","current":-26.198104,"twenty":-9.23713,"median":-5.085831,"eighty":-3.944911,"marketCap":4066024290},{"date":"2026-04-17","current":-38.738151,"twenty":-9.365612,"median":-5.125877,"eighty":-3.981637,"marketCap":6012277252},{"date":"2026-04-24","current":-38.48249,"twenty":-9.54815,"median":-5.141783,"eighty":-3.990939,"marketCap":5972597947},{"date":"2026-05-01","current":-41.378125,"twenty":-11.574571,"median":-5.163524,"eighty":-3.996385,"marketCap":6422009203},{"date":"2026-05-08","current":-35.378246,"twenty":-11.912235,"median":-5.194337,"eighty":-4.002987,"marketCap":6348095594},{"date":"2026-05-15","current":-36.612371,"twenty":-12.227731,"median":-5.199556,"eighty":-4.01025,"marketCap":6569540789},{"date":"2026-05-22","current":-35.96869,"twenty":-12.66317,"median":-5.24323,"eighty":-4.012918,"marketCap":6454041922},{"date":"2026-05-29","current":-34.899115,"twenty":-14.84662,"median":-5.263514,"eighty":-4.014565,"marketCap":6262122753},{"date":"2026-06-05","current":-37.982008,"twenty":-15.625828,"median":-5.295394,"eighty":-4.016676,"marketCap":6815301535},{"date":"2026-06-12","current":-39.0903,"twenty":-15.934177,"median":-5.346464,"eighty":-4.018572,"marketCap":7014168004},{"date":"2026-06-18","current":-42.342582,"twenty":-16.532126,"median":-5.375072,"eighty":-4.022327,"marketCap":7597741224},{"date":"2026-06-26","current":-42.913667,"twenty":-16.744637,"median":-5.470693,"eighty":-4.034149,"marketCap":7700213903},{"date":"2026-07-02","current":-43.020141,"twenty":-17.038402,"median":-5.524211,"eighty":-4.045526,"marketCap":7719318979},{"date":"2026-07-10","current":-47.79209,"twenty":-17.157159,"median":-5.623342,"eighty":-4.04736,"marketCap":8575573733},{"date":"2026-07-17","current":-46.12579,"twenty":-17.21862,"median":-5.641652,"eighty":-4.048014,"marketCap":8276581215},{"date":"2026-07-24","current":-49.002526,"twenty":-17.305083,"median":-5.684807,"eighty":-4.051257,"marketCap":8792768335},{"date":"2026-07-31","current":-49.742539,"twenty":-17.37592,"median":-5.758017,"eighty":-4.05376,"marketCap":8925552415},{"date":"2026-08-07","current":-50.967094,"twenty":-17.454049,"median":-5.886958,"eighty":-4.070861,"marketCap":9118930466},{"date":"2026-08-14","current":-50.193372,"twenty":-17.542596,"median":-5.928557,"eighty":-4.072986,"marketCap":8980497659},{"date":"2026-08-21","current":-53.120702,"twenty":-17.704063,"median":-5.957984,"eighty":-4.07743,"marketCap":9504249805},{"date":"2026-08-28","current":-46.135027,"twenty":-18.037414,"median":-6.00579,"eighty":-4.082736,"marketCap":8254386729}],"updateTime":1788236843793},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SYRE\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1196395365","title":"Spyre Therapeutics宣佈Skyway籃子試驗完成患者入組，評估Spy072（抗TL1A）治療RA、PsA及AxSpa","url":"https://stock-news.laohu8.com/highlight/detail?id=1196395365","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196395365?lang=zh_tw&edition=fundamental","pubTime":"2026-06-03 20:08","pubTimestamp":1780488531,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics Inc (SPYRE THERAPEUTICS INC) 已宣布，其针对Spy072（一种抗TL1A疗法）的Skyway篮子试验患者入组工作现已完成。该试验旨在评估该疗法对类风湿关节炎（RA）、银屑病关节炎（PsA）以及中轴型脊柱关节炎（AxSpa）患者的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146674317","title":"Spyre Therapeutics重申預期：類風濕關節炎試驗數據將於2026年第三季度揭曉，銀屑病關節炎與中軸型脊柱關節炎數據預計第四季度公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1146674317","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146674317?lang=zh_tw&edition=fundamental","pubTime":"2026-06-03 20:06","pubTimestamp":1780488378,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics公司再次确认其关键临床试验的预期数据公布时间线。针对类风湿关节炎（Ra）的研究数据，预计将在2026年第三季度获得并公布。此外，关于银屑病关节炎（Psa）以及中轴型脊柱关节炎（Axspa）的试验数据，公司则预计将在2026年第四季度陆续揭晓。\n这一时间表的重申，为关注该公司研发管线的投资者提供了明确的关键节点。不同适应症的数据分阶段出炉，或将影响市场对公司未来前景的评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162858091","title":"Spyre Therapeutics：Skyway與Skyline試驗齊頭並進，計劃中的「2026年六項」二期數據讀出已就緒並按計劃推進","url":"https://stock-news.laohu8.com/highlight/detail?id=1162858091","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162858091?lang=zh_tw&edition=fundamental","pubTime":"2026-06-03 20:06","pubTimestamp":1780488377,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics宣布，其Skyway与Skyline临床试验项目进展顺利，原定于2026年完成的六项二期研究数据读出已具备条件，并正按既定时间表稳步推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179769071","title":"Spyre Therapeutics重大協議觸發條款：2028年6月1日後初始領域外給藥限制將解除","url":"https://stock-news.laohu8.com/highlight/detail?id=1179769071","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179769071?lang=zh_tw&edition=fundamental","pubTime":"2026-06-02 04:06","pubTimestamp":1780344382,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）的一份文件披露，Spyre Therapeutics Inc.已达成一项重大协议。该协议包含一项关键条款：自2028年6月1日起，针对初始领域之外的给药限制将被解除。这一变动标志着公司研发管线在特定时间点后将获得更广泛的开发自由度，可能为后续临床试验的拓展铺平道路。文件显示，此次协议触发的限制解除是预先设定的条件之一，符合公司长远的战略规划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150438791","title":"Spyre Therapeutics 與 Paragon Therapeutics 簽署許可協議首次修訂案","url":"https://stock-news.laohu8.com/highlight/detail?id=1150438791","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150438791?lang=zh_tw&edition=fundamental","pubTime":"2026-06-02 04:05","pubTimestamp":1780344311,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics Inc (股票代码: SYRE) 于2026年5月29日，与Paragon Therapeutics就其许可协议签署了第一份修订案。该信息已通过美国证券交易委员会（SEC）文件正式披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138781160","title":"Spyre Therapeutics公布2026年一季度財務數據：現金及等價物達7.415億美元 資金可支撐運營至2029年下半年","url":"https://stock-news.laohu8.com/highlight/detail?id=1138781160","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138781160?lang=zh_tw&edition=fundamental","pubTime":"2026-05-05 20:11","pubTimestamp":1777983099,"startTime":"0","endTime":"0","summary":"生物制药公司Spyre Therapeutics Inc最新财务数据显示，截至2026年3月31日，公司持有的现金、现金等价物及有价证券总额达到7.415亿美元。这一资金规模预计能为公司持续运营提供充足保障，资金跑道将延续至2029年下半年。\n值得注意的是，强劲的现金储备为Spyre Therapeutics推进其创新疗法研发提供了坚实后盾。在当前生物科技领域融资环境充满挑战的背景下，该公司依然保持着稳健的财务态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627628710","title":"BUZZ-Spyre Therapeutics 在 4.03 億美元的股票銷售提振後上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2627628710","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627628710?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 21:20","pubTimestamp":1776259234,"startTime":"0","endTime":"0","summary":"4月15日 - ** Spyre Therapeutics公司SYRE.O股价在盘前上涨2.3%至65.50美元，此前该公司超计划筹资4.03亿美元。** 随后，该公司于周一晚些时候  启动了 3 亿美元的股票发行。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nL4S40Y18I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU0742534661.SGD","IE0004086264.USD","GSX","LU1668664300.SGD","LU2237443895.HKD","LU0251131958.USD","BK4550","LU1894683264.USD","IE0034235188.USD","LU1894683348.USD","LU2471134952.CNY","LU0061475181.USD","LU2471134796.USD","LU1868836591.USD","BK4588","LU0096364046.USD","BK4559","LU1868837136.USD","LU0345770993.USD","SYRE","EVR","LU2237443978.SGD","IE00B19Z3581.USD","LU2237443622.USD","LU2471134879.HKD","LU2471134523.USD","LU2750360641.GBP","BK4552","IE0002270589.USD","LU1868836914.USD","LU2750360997.AUD","BK4127","LU0345770308.USD","LU2265009873.SGD","LU0106831901.USD","IE00B19Z3B42.SGD","LU2237443382.USD","LU1868836757.USD","IE00BFXG1179.USD","JEF","LU2237438978.USD","LU0251142724.SGD","IE0004091025.USD","LU2237443549.SGD","BK4516","BK4504","LU0048573561.USD","LU1804176565.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120556014","title":"異動解讀 | Spyre Therapeutics獲強力買入評級，盤前大漲6.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=1120556014","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120556014?lang=zh_tw&edition=fundamental","pubTime":"2026-04-14 21:31","pubTimestamp":1776173485,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics Inc（SYRE）今日盘前股价大涨6.99%，引起了市场的关注。消息面上，Raymond James分析师马丁・奥斯特首次覆盖Spyre Therapeutics，并给予其“强力买入”评级，目标价设定为80美元。该目标价显著高于公司股票周一63.27美元的收盘价，这向市场传递了积极的信号，增强了投资者对公司未来股价表现的信心，从而推动了股价在盘前交易中上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627469264","title":"【券商聚焦】華爾街頂尖分析師調整閃迪等多家企業評級展望","url":"https://stock-news.laohu8.com/highlight/detail?id=2627469264","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627469264?lang=zh_tw&edition=fundamental","pubTime":"2026-04-14 20:12","pubTimestamp":1776168740,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华尔街头部分析师近期陆续更新多家热门上市公司的投资评级与目标价：Evercore ISI分析师阿米特达里亚尼首次覆盖闪迪 ，给予其跑赢大盘评级，设定目标价 1200 美元。摩根士丹利分析师罗纳德坎德姆首次覆盖Janus Living，给出增持评级，目标价定为 28 美元。Evercore ISI 分析师彼得莱文首次覆盖边缘云服务商Fastly，评级为跑赢大盘，目标价 32 美元，该股周一收盘价 24.37 美元。","market":"other","thumbnail":"https://static.szfiu.com/news/20210810/ZWQyMzQ4MWViNTBlNjYyZWIyNzg3MGMyMTYyODU5MDY5NTc1OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZWQyMzQ4MWViNTBlNjYyZWIyNzg3MGMyMTYyODU5MDY5NTc1OQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"299168","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAN","SNDK","BK4007","SYRE","LU0963586101.USD","BK4585","BK4170","BK4120","BK4588","BK4554","BK4608","BK4139","BK4116","BK4225","BK4613","FSLY","LU0054578231.USD","SNXX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104189294","title":"Spyre Therapeutics公司宣佈暫停並終止ATM發行招股説明書 2026年4月13日正式生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1104189294","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104189294?lang=zh_tw&edition=fundamental","pubTime":"2026-04-14 04:31","pubTimestamp":1776112280,"startTime":"0","endTime":"0","summary":"根据最新提交给美国证券交易委员会的文件显示，生物制药公司Spyre Therapeutics Inc已决定暂停并终止其在场内发行计划相关的招股说明书。该决定将于2026年4月13日正式生效。这意味着Spyre Therapeutics公司将不再通过ATM发行方式出售普通股。ATM发行是一种灵活的融资方式，允许上市公司在需要时通过经纪商在公开市场上逐步出售股票。暂停和终止ATM招股说明书的举措，通常意味着公司短期内不会通过该渠道进行股权融资。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627045446","title":"BUZZ--美國股票走勢-Allogene Therapeutics、Adobe、Williams-Sonoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2627045446","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627045446?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 23:45","pubTimestamp":1776095125,"startTime":"0","endTime":"0","summary":"nL6N40W0G6 ** Ocular Therapeutix Inc OCUL.O:BUZZ - 由于新眼药显示疾病控制时间更长而上涨 nL4N40W0TJ ** Spyre Therapeutics Inc SYRE.O:BUZZ - 因肠道疾病药物中期研究成功而上涨 nL6N40W0OH ** Alphabet Inc GOOGL.O：** Meta Platforms Inc META.O：** Snap Inc SNAP.N：** Pinterest Inc PINS.N：BUZZ - 因地缘政治动荡和能源价格，Stifel 下调数字广告增长预期 nL4N40W0RX ** ImageneBio Inc IMA.O:BUZZ--为资助脱发和皮肤病药物融资 3,000 万美元后股价上涨 nL4N40W0UI ** 国际商业机器公司IBM.N：BUZZ - 花旗集团开始对 IBM 进行 \"买入 \"评级。nL6N40W0O3 ** Best Buy Co Inc BBY.N:BUZZ - 因高盛将其评级双双下调至 \"卖出 \"而下滑。nL6N40W0RY ** Revolution Medicines Inc RVMD.O:BUZZ - 因胰腺癌药物","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL4T40W1DN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DOW","DVN","REPL","RIOT","XOM","RVMD","HL","IMA","OCUL","GPRO","TFX","HPE","BBY","SYRE","AVT","OWL","SNDK","CRWV","LEG","DAL","WSM","LUV","SBUX","UAL","GOOGL","IDYA","KYMR","GGLS","COIN","PINS","ANIP","APTV","EMN","HTFL","IBM","CVX","LYB","NEM","AAL","CAG","MARA","META","OXY","BIIB","DIOD","ALLO","HUT","ADBE","CDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627454667","title":"BUZZ-腸道疾病藥物中期研究成功，Spyre 股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2627454667","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627454667?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 23:34","pubTimestamp":1776094492,"startTime":"0","endTime":"0","summary":"4月13日 - ** 药物开发商Spyre Therapeutics SYRE.O的股价上涨19.8%，达到61.42美元的四年多新高，结束了连续两天的下跌走势。** 溃疡性结肠炎是一种慢性炎症性疾病，会导致结肠和直肠内壁肿胀和溃疡** 截至上一交易日收盘，SYRE股价年累计上涨56%(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL4S40W1D0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169388124","title":"Spyre Therapeutics高管：中期研究顯示SPY001單藥療效在部分指標上媲美或超越強生聯合療法","url":"https://stock-news.laohu8.com/highlight/detail?id=1169388124","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169388124?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 20:24","pubTimestamp":1776083056,"startTime":"0","endTime":"0","summary":"在中期临床试验中，Spyre Therapeutics公司高管透露，其核心候选药物SPY001作为单药治疗时，在部分关键疗效指标上达到甚至超过了强生联合疗法的表现。这一突破性数据来自该公司最新举行的电话会议。\n值得注意的是，SPY001单药疗法展现出的疗效水平与强生多药联合方案相当，特别是在某些预设的临床终点上表现出色。该结果预示着SPY001可能成为相关疾病治疗领域的重要创新方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","LU2471134879.HKD","LU2129689514.USD","LU1023059063.AUD","SG9999013999.USD","LU0114720955.EUR","IE00BLSP4452.SGD","SGXZ57979304.SGD","LU0289739699.SGD","BK4533","LU2129689605.HKD","LU1718418525.SGD","BK4550","LU1732800096.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0203345920.USD","BK4532","LU0640476718.USD","IE0009355771.USD","IE0001KFT4U8.USD","IE00BBT3K403.USD","LU0689626769.HKD","BK4534","LU1983299246.USD","SYRE","LU2471134952.CNY","IE00BJT1NW94.SGD","LU0432979614.USD","LU1066051225.USD","LU1929549753.HKD","LU2112291526.USD","JNJ","IE00B3T34201.USD","LU1121112475.USD","LU2347655156.SGD","LU1674673428.USD","BK4559","LU1066051498.USD","IE0002141913.USD","LU0426412945.USD","LU1894683264.USD","BK4568","LU1267930813.SGD","LU1914381329.SGD","SG9999002232.USD","LU1061106388.HKD","LU1496350502.SGD","IE0034235303.USD","LU1043141123.HKD","IE00B2B36J28.USD","LU1196500208.SGD","LU1074936037.SGD","LU1585245621.USD","LU0058720904.USD","LU0426417589.USD","IE00BDGV0183.EUR","IE00BGHQF631.EUR","LU0889566641.SGD","IE00B19Z3581.USD","LU1162221912.USD","IE0000B7K699.USD","LU0320765646.SGD","LU1732799900.SGD","IE000MB6IJN5.SGD","IE00BFXG1179.USD","IE00BLSP4239.USD","IE00B3PB1722.GBP","LU1935042991.SGD","LU0787776722.HKD","LU2750360997.AUD","LU0070217475.USD","LU2129689431.USD","LU1221951046.USD","IE00B1BXHZ80.USD","BK4504","IE00BVYPNV92.GBP","LU0124676726.USD","LU2430703251.USD","LU2468319806.SGD","LU2505996509.AUD","LU1221951129.SGD","SG9999001440.SGD","LU1430594728.SGD","IE00B7SZLL34.SGD","LU2430703095.HKD","LU0912757837.SGD","LU1244550494.USD","LU0345769631.USD","LU0098860793.USD","SG9999001176.SGD","LU1057294990.SGD","LU0795875086.SGD","LU0792757196.USD","LU2133065610.SGD","IE00BKVL7J92.USD","LU0994945656.USD","IE000BZT7R73.USD","LU0882574055.USD","LU1032955483.USD","IE0002270589.USD","LU0122379950.USD","IE00BJJMRZ35.SGD","LU1066051811.HKD","BK4007","IE00BZ1G4Q59.USD","IE00BVYPNW00.USD","LU1066053197.SGD","IE000SO60NU8.SGD","LU1261432733.SGD","SG9999001176.USD","LU0234572021.USD","LU1059921491.USD","LU0466842654.USD","IE000F7OJYX1.SGD","LU0683600562.USD","LU0795875169.SGD","IE00B19Z3B42.SGD","LU1043141396.HKD","LU2592432038.USD","LU2505996681.GBP","BK4588","LU1244550221.USD","SG9999002224.SGD","LU0345769128.USD","BK4139","IE000WAW04H5.SGD","LU2471134523.USD","BK4592","LU0234570918.USD","LU0345770308.USD","IE00BN8TJ469.HKD","LU1032466523.USD","BK4581","IE00BSNM7G36.USD","LU0203347892.USD","BK4585","LU2602419157.SGD","LU0985320562.USD","LU2471134796.USD","IE00B42XCP33.USD","LU2750360641.GBP","LU1244550577.SGD","LU1778281490.HKD","LU0345770993.USD","LU2430703178.SGD","LU1280957306.USD","LU1674673691.USD","LU1506573853.SGD","LU2089984988.USD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627458246","title":"Spyre盤前股價上漲23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627458246","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627458246?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 19:47","pubTimestamp":1776080820,"startTime":"0","endTime":"0","summary":"每经AI快讯，4月13日，Spyre盘前股价上涨23%。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-04-13/doc-inhukeex9689769.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-04-13/doc-inhukeex9689769.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0353189680.USD","LU1861215975.USD","AIYY","IE00B19Z9P08.USD","BK4551","BK4539","LU1861220033.SGD","IE00B894F039.SGD","APPX","BK4585","LU2360106780.USD","BK4608","BK4588","BK4587","LU2360107168.USD","IE00BZ9MQY76.HKD","IE00B19Z9Z06.USD","LU0353189763.USD","LU2087625088.SGD","BK4543","LU0097036916.USD","BK4023","SYRE","BK4528","LU2063271972.USD","LU1852331112.SGD","LU0056508442.USD","LU2250418816.HKD","LU2290526834.HKD","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188201235","title":"SPYRE THERAPEUTICS INC股價盤前飆升23% 公司宣佈炎症性腸病藥物中期研究顯示疾病活動度降低","url":"https://stock-news.laohu8.com/highlight/detail?id=1188201235","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188201235?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 19:46","pubTimestamp":1776080778,"startTime":"0","endTime":"0","summary":"SPYRE THERAPEUTICS INC股价在盘前交易中大幅上涨23%，此前该公司宣布其针对炎症性肠病的药物在一项中期研究中显示出能够显著降低疾病活动度。\n这一积极的研究结果提振了投资者信心，推动该公司股价在开盘前即迎来强劲涨势。该药物在临床试验中达到主要终点，为患有此类慢性肠道疾病的患者带来了新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191160307","title":"Spyre公布Skyline試驗中重度潰瘍性結腸患者Spy001 Part a誘導期潛在最佳療效數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1191160307","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191160307?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 19:09","pubTimestamp":1776078591,"startTime":"0","endTime":"0","summary":"生物制药公司Spyre Therapeutics公布了其Skyline临床试验中针对中重度溃疡性结肠炎患者的Spy001 Part a诱导期研究结果，数据显示该疗法可能具备同类最优潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197836690","title":"Spyre Therapeutics：誘導治療期間六名受試者出現治療突發不良事件","url":"https://stock-news.laohu8.com/highlight/detail?id=1197836690","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197836690?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 19:00","pubTimestamp":1776078043,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics公司在诱导治疗阶段报告了六例治疗相关不良事件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175357309","title":"Spyre Therapeutics藥物Spy001達成主要終點：RHI評分顯著降低9.2分，統計學差異凸顯","url":"https://stock-news.laohu8.com/highlight/detail?id=1175357309","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175357309?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 19:00","pubTimestamp":1776078031,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics Inc宣布，其候选药物Spy001在临床试验中成功达成主要研究终点。数据显示，该药物使RHI评分出现具有统计学意义的显著下降，降幅达到9.2分。这一积极结果标志着项目取得了重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627325284","title":"Spyre公司的炎症性腸病藥物在中期研究中減輕了疾病活動性","url":"https://stock-news.laohu8.com/highlight/detail?id=2627325284","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627325284?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 19:00","pubTimestamp":1776078022,"startTime":"0","endTime":"0","summary":"Spyre公司的炎症性肠病药物在中期研究中减轻了疾病活动性路透4月13日 - Spyre Therapeutics &SYRE.O> 周一称，在一项针对溃疡性结肠炎患者的中期研究中，其实验性药物的疾病活动明显减少。溃疡性结肠炎是一种慢性炎症性疾病，会导致结肠和直肠内壁肿胀和溃疡。武田的Entyvio于2014年5月获得美国食品药品管理局批准，用于治疗中度至重度活动性溃疡性结肠炎；皮下注射版本于2023年9月获得批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL4T40W0QC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152663853","title":"Spyre Therapeutics次要終點數據亮眼：改良Mayo評分臨床緩解率達40%，內鏡改善率51%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152663853","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152663853?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 19:00","pubTimestamp":1776078015,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics公司最新研究数据显示，其次要疗效终点取得显著成果。根据改良Mayo评分标准，患者临床缓解率达到40%，同时内镜下黏膜改善率表现更为突出，达到51%的水平。\n该数据反映了候选疗法在炎症性肠病治疗领域的潜在价值，两项关键指标共同印证了治疗方案的临床有效性。值得注意的是，内镜改善率超过临床缓解率11个百分点，提示该疗法可能对黏膜愈合具有特别优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SYRE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":42,"code":"91000000","status":"200"}]}}